Structural Heart Devices Market Size, Share, Growth and Value 2032

Structural Heart Devices Industry Prospective:

The global Structural Heart Devices market size accrued earnings worth approximately USD 14.83 Billion in 2023 and is predicted to gain revenue of about USD 34.20 Billion by 2032, is set to record a CAGR of nearly 9.73% over the period from 2024 to 2032.

The study includes the drivers and restraints of the Structural Heart Devices Market along with the impact they have on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the Structural Heart Devices Market on a global level.

Request Free Sample

Structural Heart Devices Market: Overview

Structural heart devices are used to maintain the normal structure of a human heart. Due to the various congenital defects and cardiovascular infections, heart muscles lose their shape. This, in turn, affects the normal functioning of the heart. Common heart structural diseases include atrial septal defects, patient foramen ovale, Paravalvular leak, etc. These devices can be placed through minimally invasive procedures, whereas a few cases need open heart surgery. Minimally invasive surgeries have reduced the risk and decreased the recovery time.

One of the major factors likely to drive the structural heart devices market globally in the future is the constant increase in the prevalence of congenital heart defects. As per the Centers for Disease Control and Prevention 2018 report, there were around 40,000 infants diagnosed with congenital heart defects in the U.S. Moreover, there is a constant increase in the demand of minimally invasive surgeries coupled with an increased recovery rate.

Furthermore, substantial increase related to technological advancements and research and development activities has resulted in the introduction of innovative products, thereby promoting the structural heart devices market growth in the future. However, the high cost of these devices and the enforcement of stringent legislation governing the approval of new devices might hamper the structural heart devices market over the estimated time span.

In order to give the users of this report a comprehensive view of the Structural Heart Devices Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Request Free Sample

Structural Heart Devices Market: Segmentation

The global structural heart devices market is classified on the basis of product type, indication, and end-user.

By product type, the structural heart devices market includes heart valve devices, occluders, and delivery systems, annuloplasty rings, and accessories. Heart valve devices are expected to dominate the structural heart devices market in the upcoming years.

By indication, the structural heart devices market is segmented into atrial septal defect (ASD), patent foramen ovale (PFO), ventricular septal defect (VSD), and aortic valve stenosis.

By end-user, the structural heart devices market is segmented into hospitals, ambulatory surgical centers, and others.

Structural Heart Devices Market: Report Scope

Structural Heart Devices Market: Regional Analysis

By region, the global structural heart devices market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to lead the structural heart devices market globally over the forecast time period, followed by Europe. The Asia Pacific region is projected to be the fastest growing region over the estimated timeframe, owing to the significant contributions made by developing economies, such as India and China. The Latin American and the Middle Eastern and African markets are anticipated to grow moderately in the future.

Structural Heart Devices Market: Competitive Analysis

The global structural heart devices market is dominated by players like:

• Abbott Laboratories
• Medtronic Plc
• Endologix Inc
• LivaNova Plc
• Boston Scientific Corporation
• CryoLife Inc
• Cook Group Incorporated
• Edwards Lifesciences Corporation
• W. L. Gore & Associates, Inc

This report segments the global structural heart devices market into:

Global Structural Heart Devices Market: Product Type Analysis

• Heart Valve Devices
• Occluders and Delivery Systems
• Annuloplasty Rings
• Accessories

Global Structural Heart Devices Market: Indication Analysis

• Atrial Septal Defect (ASD)
• Patent Foramen Ovale (PFO)
• Ventricular Septal Defect (VSD)
• Aortic Valve Stenosis

Global Structural Heart Devices Market: End-User Analysis

• Hospitals
• Ambulatory Surgical Centers

• Others

Global Structural Heart Devices Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa